Pelvic Inflammatory Disease
📧 Sign up to get email alerts when something new happens for Pelvic Inflammatory Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Surgical Success After Laparoscopic vs Abdominal Hysterectomy [NA]
A completed clinical trial comparing laparoscopic versus abdominal hysterectomy to assess surgical success for conditions commonly treated w…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
Pfizer completed a post-marketing drug-use investigation of intravenous azithromycin for pneumonia and pelvic inflammatory disease, with res…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) [Phase 2]
Phase 2 clinical trial evaluating anti-anaerobic therapy for acute pelvic inflammatory disease has completed and results were posted in 2016…
-
CLINICAL_TRIALS research · 2016-11-23Clinical Trial Update: Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae [Phase 2]
This entry reports a Phase 2 clinical trial by Shanghai University of Traditional Chinese Medicine evaluating traditional Chinese medicine f…
-
FDA approval · 2016-11-16FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approved Metronidazole via an original application from Viona Pharmaceuticals Inc (ANDA206560). The approval confirms its use for anaero…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: The Role of Novel Organisms in Acute Endometritis
This document provides an update on a completed clinical trial investigating the role of novel organisms in acute endometritis, in the conte…
-
FDA approval · 2016-06-29FDA Approved: CEFTRIAXONE SODIUM — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved the Original Application for ceftriaxone sodium from Qilu Pharmaceutical Co., Ltd., a broad-spectrum cephalosporin used to trea…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease [NA]
This document notes that a community-based screening trial for Chlamydia trachomatis to prevent pelvic inflammatory disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease [NA]
A completed clinical trial examining approaches to improve primary care follow-up for patients with Pelvic Inflammatory Disease.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. [Phase 3]
Phase 3 trial evaluating moxifloxacin for uncomplicated pelvic inflammatory disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials [Phase 4]
Phase 4 multicenter randomized trial comparing moxifloxacin to ofloxacin plus metronidazole for uncomplicated pelvic inflammatory disease ha…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy [NA]
A completed clinical trial compared universal antibiotic prophylaxis to screen-and-treat to reduce infective complications and reinfection i…
-
FDA approval · 2012-12-18FDA Approved: AZITHROMYCIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for azithromycin submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-03-28FDA Approved: METRONIDAZOLE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for metronidazole filed by Taro Pharmaceuticals U.S.A., Inc. (ANDA077819).
-
FDA approval · 2012-03-28FDA Approved: METRONIDAZOLE — Supplemental Application (AMICI PHARMA INC)
The FDA approved a supplemental application for metronidazole submitted by Amici Pharma Inc, resulting in updated labeling related to its in…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan [Phase 3]
Phase 3 clinical trial evaluating an intravenous azithromycin formulation for pelvic inflammatory disease in Japan has completed and posted …
-
FDA approval · 2011-09-30FDA Approved: CLINDAMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for CLINDAMYCIN PHOSPHATE (clindamycin), a generic antibiotic for treating suscept…
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment [Phase 4]
A Phase 4 clinical trial comparing Ofloxacin to Azithromycin for pelvic inflammatory disease has completed.
-
FDA approval · 2010-05-05FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for Metronidazole from Alembic Pharmaceuticals Limited (generic approval).
-
CLINICAL_TRIALS trial_result · 2009-11-30Clinical Trial Update: A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease [Phase 3]
Phase 3 trial comparing moxifloxacin monotherapy vs levofloxacin plus metronidazole for uncomplicated pelvic inflammatory disease; the study…
-
FDA approval · 2009-08-06FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's supplemental application for metronidazole under NDA 018657.
-
FDA approval · 2009-06-23FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic Metronidazole product.
-
FDA approval · 2009-06-18FDA Approved: CEFTRIAXONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for ceftriaxone sodium (ceftriaxone) from Baxter Healthcare Company, authorizing changes to the appr…
-
FDA approval · 2009-06-12FDA Approved: CEFOXITIN — Original Application (WG Critical Care, LLC)
FDA approves Cefoxitin (cefoxitin) under an original application from WG Critical Care, LLC.
-
FDA approval · 2007-06-27FDA Approved: METRONIDAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Metronidazole from Chartwell RX, LLC (ANDA number 076522).